EFFECT OF KETAMINE NEBULIZATION IN ACUTE RESPIRATORY DISTRESS SYNDROME
Phase 1
- Conditions
- Health Condition 1: J989- Respiratory disorder, unspecified
- Registration Number
- CTRI/2024/07/071197
- Lead Sponsor
- King George Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age 20-50 years
Mechanically ventilated adult patients admitted to the
ICU with developing ARDS.
Exclusion Criteria
Pregnant women
Patient/Attendant not giving consent
Underlying cardiac, and neurological disorders
Previous history of psychiatric disorder / substance abuse APACHE Score =25
Patient expiring within 3 days of initiation of therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the therapeutic effect of ketamine nebulization in ARDS based on Murray Score.Timepoint: 28 Days
- Secondary Outcome Measures
Name Time Method To evaluate effect of ketamine nebulization on 28 days mortality in ARDS patientsTimepoint: 28 days;To evaluate the effect of ketamine nebulization on IL-6 levels in ARDS patients on Day 1, 3 & 5.Timepoint: 5 days